Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 61 of the 64 references it cites were found in a registry or an index.

Global incidence and mortality of severe fungal disease

Open access
Denning, David W·2024·The Lancet Infectious Diseases

Abstract

Current estimates of fungal disease incidence and mortality are imprecise. Population at risk denominators were used to estimate annual incidence for 2019-21. Extensive literature searches from 2010 to 2023 were combined with over 85 papers on individual country and global disease burden. Crude and attributable mortality were estimated using a combination of untreated mortality, the proportion of patients who are treated, and percentage survival in treated patients. Awareness, guidelines, and accessibility of diagnostics and therapies informed the ratio of treated to untreated cases. Estimates do not include influenza or COVID-19 outbreaks. Data from more than 120 countries were included. Annually, over 2 113 000 people develop invasive aspergillosis in the context of chronic obstructive pulmonary disease, intensive care, lung cancer, or haematological malignancy, with a crude annual mortality of 1 801 000 (85·2%). The annual incidence of chronic pulmonary aspergillosis is 1 837 272, with 340 000 (18·5%) deaths. About 1 565 000 people have a Candida bloodstream infection or invasive candidiasis each year, with 995 000 deaths (63·6%). Pneumocystis pneumonia affects 505 000 people, with 214 000 deaths (42·4%). Cryptococcal meningitis affects 194 000 people, with 147 000 deaths (75·8%). Other major life-threatening fungal infections affect about 300 000 people, causing 161 000 deaths (53·7%). Fungal asthma affects approximately 11·5 million people and might contribute to 46 000…

Overview

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(23)00692-8

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 64 references

Research works printed but not linked: 1

  1. Ning, 2020, The global distribution, drivers, and burden of talaromycosis 1964–2018, Conference of Retrovirus and Opportunistic Infections

Cited by

See all 1,640

Metadata

Authors
Denning, D. W.
Affiliations
University of Manchester (GB)
Corresponding author
Denning, David W
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2024-07
Volume
24
Issue
7
Pages
e428-e438
ISSN
1473-3099 (ISSN-L)
OpenAlex
W4390919957
Cited by
1,640
References
64
Citations by year
2026: 681 · 2025: 666 · 2024: 292
FWCI
136.24
Type
journal article
Language
en
Open access
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • SSRN Electronic Journal (acceptedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
Canadian Institute for Advanced Research
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
invasive fungal infections, global burden of disease, incidence, mortality, invasive aspergillosis, chronic pulmonary aspergillosis, invasive candidiasis, candidemia, Pneumocystis carinii pneumonia, cryptococcal meningitis, fungal asthma, attributable mortality, vulnerable populations
MeSH terms
Humans, Mycoses, Global Health, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global incidence and mortality of severe fungal disease. https://app.cochat.ai/papers/10.1016/s1473-3099(23)00692-8
The paper
Denning, D. W. (2024). Global incidence and mortality of severe fungal disease. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(23)00692-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.